BG Medicine, Inc. to Present at Robert W. Baird 2012 Health Care Conference
August 30, 2012 16:09 ET
|
BG Medicine, Inc.
WALTHAM, Mass., Aug. 30, 2012 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD), a company focused on the development and commercialization of novel, biomarker-based diagnostics, announced today...
BG Medicine, Inc. Announces Publication of Important Galectin-3 Study Designed to Identify Adults in General Population at Risk for Heart Failure
August 30, 2012 08:30 ET
|
BG Medicine, Inc.
WALTHAM, Mass., Aug. 30, 2012 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD), a company focused on the development and commercialization of novel cardiovascular diagnostics, announced today that...
BG Medicine Announces Fiscal 2012 Second Quarter Results
August 09, 2012 08:00 ET
|
BG Medicine, Inc.
WALTHAM, Mass., Aug. 9, 2012 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD) today announced its consolidated results of operations for the three and six months ended June 30, 2012 and provided a...
BG Medicine Announces Second Quarter 2012 Financial Results Release Date and Conference Call Information
August 02, 2012 18:00 ET
|
BG Medicine, Inc.
WALTHAM, Mass., Aug. 2, 2012 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD) today announced that its financial results for the second quarter of fiscal year 2012 will be released before market...
BG Medicine, Inc. Announces 510(k) Filing for the ARCHITECT Galectin-3 Assay on the Abbott ARCHITECT Automated Platform
July 20, 2012 08:30 ET
|
BG Medicine, Inc.
WALTHAM, Mass, July 20, 2012 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD), a company focused on the development and commercialization of novel cardiovascular diagnostics, today announced the...
BG Medicine, Inc. to Present at the JMP Securities Healthcare Conference
July 09, 2012 08:30 ET
|
BG Medicine, Inc.
WALTHAM, Mass., July 9, 2012 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD), a company focused on the development and commercialization of novel cardiovascular diagnostics, announced today that...
BG Medicine, Inc. Appoints Bill Densel, General Manager, CardioSCORE
July 02, 2012 08:30 ET
|
BG Medicine, Inc.
WALTHAM, Mass., July 2, 2012 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD), a company focused on the development and commercialization of novel cardiovascular diagnostics, announced today that...
BG Medicine, Inc. Announces Availability of Galectin-3 Diagnostic Testing Through Atherotech Diagnostics Lab
June 18, 2012 08:30 ET
|
BG Medicine, Inc.
WALTHAM, Mass., June 18, 2012 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD), a company focused on the development and commercialization of novel cardiovascular diagnostics, announced today that...
BG Medicine Announces Fiscal 2012 First Quarter Results
May 15, 2012 07:00 ET
|
BG Medicine, Inc.
WALTHAM, Mass., May 15, 2012 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD) today announced its consolidated results of operations for the first quarter of fiscal year 2012 and provided a...
BG Medicine, Inc. Obtains CE Mark and Files 510(k) for Expanded BGM Galectin-3(TM) Indication
May 15, 2012 06:45 ET
|
BG Medicine, Inc.
WALTHAM, Mass., May 15, 2012 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD), a company focused on the development and commercialization of novel cardiovascular diagnostics, announced today that...